Navid Hafez

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Adagrasib in Advanced Solid Tumors Harboring a<i>KRAS</i>^<i>G12C</i>Mutation

Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira et al. · Journal of Clinical Oncology · 2023 · 276 citations · Full text

Medicine, Oncology, Pharmacology +13

Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy

Jacob Siegel, Mariam Totonchy, William Damsky et al. · Journal of the American Academy of Dermatology · 2018 · 204 citations

Medicine, Oncology, Pathology +17

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Hematology, Oncology +10

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Matthew D. Hellmann, Pasi A. Jänne, Mateusz Opyrchal et al. · Clinical Cancer Research · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +17